In a new article in The Lancet, researchers from Leiden University Medical Center in the Netherlands have provided a systematic review of health related quality of life publications of phase III randomised controlled trials in metastatic hormone-sensitive prostate cancer. You can view the paper here.

In this American study, the authors investigated the potential role of agricultural pesticide exposure in prostate cancer incidence and mortality. The results suggest a potential link between certain pesticides and increased prostate cancer .
Read the article, published in Cancer, here.

Australian urologists have created a short film using AI to raise awareness about prostate cancer and encourage men to have vital conversations with their doctors about PSA screening. The film is designed to break down myths and inspire informed decision-making about prostate cancer testing.

You can read a summary of an important plenary session at the EMUC24 congress, examining the current evidence in screening programmes such as the trials Swedish Organised Prostate Cancer Testing (OPT), PROBASE and TRANSFORM, as well as the Prostate cancer awareness and initiative for screening in the European Union (PRAISE-U)

Read the article here.

The European Association of Urology has issued a podcast on “Prostate cancer indication for biopsy and screening”, where urologist Roderick van den Bergh and Europa Uomo’s Vice Chairman Erik Briers discuss the dynamics of prostate cancer diagnostics, and the latest advances in screening methods, including the updates to diagnostic algorithms that are reshaping clinical practice.

Listen to the webcast here.

You can find details of Europa Uomo’s Important new EU-PRESS study into shared decision making on our website at https://www.europa-uomo.org/eu-press/ Please take part in our survey if you have discussed prostate cancer treatment with your doctors since January 2022. The direct link to the survey is https://eupress.eu/

And please publicise the survey as widely as possible to your contacts and members. We are depending on your help to get a good response. There is artwork for X and Facebook posts that you can use, and which can also be inserted into newsletters, emails and other communications.

You can find the Europa Uomo/EAU chatbot, trained through AI in the EAU’s prostate cancer guidelines, on every page of the Europa Uomo website (europa-uomo.org) in the lower right corner. See images below.

The chatbot is available in 99 languages. It always starts in English, but you can easily ask questions in your own language and then the chatbot will respond in your own language.

Please try it yourself.

Let’s Talk Prostate Cancer (LTPC) will kick off its work in the new European Parliament with a special event aiming to ensure that men’s health remains a priority year-round and shine a spotlight on prostate cancer. With the inauguration of the new European Commission, LTPC sees a unique opportunity to raise awareness and drive action. Europa Uomo’s André Deschamps and Hein Van Poppel will be on the speakers’ list. More information and registration here.

In this BBC interview and article, Sir Chris Hoy (a former track cyclist and racing driver from Scotland), talks about his stage four prostate cancer diagnosis and how he told his family. He shares how he wants to bring hope to others with stage four cancer, and how he wants to raise awareness and testing for prostate cancer.